Table 3 Clinical information of tissue microarray.
From: Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration
Characteristic | Total number (N = 70) | ||
|---|---|---|---|
Numbers (n) | % | ||
Ages |  < 60 y | 30 | 42.86% |
 ≥ 60 y | 40 | 57.14% | |
Gender | Male | 60 | 85.71% |
Female | 10 | 14.29% | |
Tumor size (shortest length) |  ≤ 3.0 cm | 35 | 50.00% |
 > 3.0 cm | 15 | 21.43% | |
Unable to calculate/not recorded | 20 | 28.57% | |
T-stage | Ta | 23 | 32.86% |
T1 | 27 | 38.57% | |
T2 | 12 | 17.14% | |
T3 | 8 | 11.43% | |
N-stage | N0 | 70 | 100% |
M-stage | M0 | 70 | 100% |
Clinical stage | 0 | 23 | 32.86% |
I | 27 | 38.57% | |
II | 12 | 17.14% | |
III | 8 | 11.43% | |
